Yongtao Sun
Quick facts
Marketed products
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Yongtao Sun
What are Yongtao Sun's marketed drugs?
Top marketed products include GroupB:Liposomal bupivacaine and bupivacaine hydrochloride;, oxalidine.